Optra-S™
Therapeutic Segment:
Anti-Asthmatic & COPD
Generic Name:
Ipratropium Bromide + Salbutamol
Indication
Nebuliser Solution - Unit Dose Vial (UDV)
- 0.5mg + 2.5mg/2.5ml
Optra-S (Ipratropium Bromide + Salbutamol) Nebuliser Solution is indicated for the:
- Symptomatic treatment of bronchospasm in adults and adolescents over 12 years of age with chronic obstructive pulmonary disease who require treatment with both Ipratropium Bromide and Salbutamol.